Chemical Structure : Rituximab
CAS No.: 174722-31-7
货号: PC-Ab1003Not For Human Use, Lab Use Only.
The first monoclonal antibody approved for cancer therapy and the first single-agent approved for therapy of lymphoma. It was approved by the FDA for the treatment of patients with relapsed or refractory low-grade or follicular, CD20-positive, B-cell non-Hodgkin's lymphoma in 1997..
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥3580 | In stock | |
5 mg | ¥7580 | In stock | |
10 mg | ¥12800 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
The first monoclonal antibody approved for cancer therapy and the first single-agent approved for therapy of lymphoma. It was approved by the FDA for the treatment of patients with relapsed or refractory low-grade or follicular, CD20-positive, B-cell non-Hodgkin's lymphoma in 1997.
分子量 | ||
分子式 | Human IgG1-Kappa | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
PBS, pH 7.0 Contains no stabilizers or preservatives |
|
Chemical Name/SMILES |
Rituximab; IDEC-C2B8; Rituxan;C2B8; MabThera; Anti-human CD20; MS4A1 gene; cluster of differentiation 20. |
1. 1, Maloney DG, et al. Blood. 1997 Sep 15;90(6):2188-95. 2, Reff ME, et al. Blood. 1994 Jan 15;83(2):435-45. 3, Demidem A, et al. Cancer Biother Radiopharm. 1997 Jun;12(3):177-86.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright